| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |